This study is in progress, not accepting new patients
A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Nicholas Butowski
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Nicholas Butowski
Professor, Neurological Surgery, School of Medicine. Authored (or co-authored) 122 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- ID
- NCT03345095
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 749 people participating
- Last Updated